Overgaard
Anders Overgaard, Frederikshavn DK
Patent application number | Description | Published |
---|---|---|
20130068389 | METHOD FOR MANUFACTURING A WIND TURBINE ROTOR BLADE WITH A SHEAR WEB - A method for manufacturing a wind turbine rotor blade with a shear web involves the following steps: Fibre material is laid onto the inner surface of a mould. A first layer of fibre material for the shear web is laid onto the fibre material which was placed onto the inner surface of the mould. Then a first mould core part is partly positioned onto the first layer of fibre material. The first mould core part has a base surface, a top surface and a surface for supporting the shear web. The first layer of fibre material is then placed along the surface for supporting the shear web and at least partly along the top surface of the first mould core part. Then the shear web is positioned at the surface of supporting the shear web of the first mould core part. | 03-21-2013 |
Emma Overgaard, Lund SE
Patent application number | Description | Published |
---|---|---|
20140097935 | Extended User Assistance - The invention relates to providing extended user assistance to the user of a portable electronic device. In particular, the invention relates to providing using assistance for a user of a portable electronic device, comprising a display and a Near Field Communication (NFC) circuit. The method comprises swiping the portable electronic device over an NFC tag comprising user assistance data, accessing user assistance information based on the user assistance data and displaying the user assistance information on the display. The application also relates to a method for providing context-based user assistance information and to a corresponding device. | 04-10-2014 |
Erik Overgaard, Osjo NO
Patent application number | Description | Published |
---|---|---|
20080230508 | REMOVABLE TEMPERATURE REGULATING MECHANISM - A container (e.g. a bottle) with a removable temperature regulating mechanism. The temperature regulating mechanism includes phase change material. The temperature regulating mechanism may maintain a liquid (e.g. sports drinks) stored in the bottle at a substantially consistent temperature (e.g. approximately 1-3 degrees Celsius) for a reasonable period of time. | 09-25-2008 |
Erik Overgaard, Oslo NO
Patent application number | Description | Published |
---|---|---|
20080308563 | SUBCONTAINER TEMPERATURE REGULATING MECHANISM - An apparatus including a container (e.g. a bottle, can, keg, box, etc.). The container may be configured to contain a consumable liquid. There may be at least one subcontainer inside the container. The subcontainer may include a temperature regulating mechanism that includes phase change material. Phase change material can maintain liquid (e.g. beer) in the container at a predetermined temperature (e.g. for beer, approximately 1-3 degrees Celsius) for a prolonged period of time. | 12-18-2008 |
20110114218 | BOTTLE - A temperature regulating mechanism is attached inside the bottle. The temperature regulating mechanism may include phase change material. The temperature regulating mechanism may maintain a liquid (e.g. Vodka) stored in the bottle at a substantially consistent temperature (e.g. approximately 10 degrees Celsius) for a reasonable period of time. | 05-19-2011 |
Henning Overgaard, Harlev J DK
Patent application number | Description | Published |
---|---|---|
20150096341 | Motorised Door Lock Actuator - Actuation system for a door lock, where the door lock comprises a lock bolt driven by rotation of a lock pin that is functionally connected to the lock bolt. The actuation system comprises a cylindrical handle ( | 04-09-2015 |
Jens Overgaard, Aarhus-C DK
Patent application number | Description | Published |
---|---|---|
20100322939 | NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS - The invention relates to a method for the treatment of an EGFR-associated tumor comprising administration, to an individual in need thereof, of an anti-EGFR antibody in combination with radiotherapy and a radiosensitising agent. In one embodiment, the treatment further comprises administration of a chemotherapeutic agent. | 12-23-2010 |
20130095112 | NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS - The invention relates to a method for the treatment of an EGFR-associated tumor comprising administration, to an individual in need thereof, of an anti-EGFR antibody in combination with radiotherapy and a radiosensitising agent. In one embodiment, the treatment further comprises administration of a chemotherapeutic agent. | 04-18-2013 |
20150111758 | GENE SIGNATURES ASSOCIATED WITH EFFICACY OF POSTMASTECTOMY RADIOTHERAPY IN BREAST CANCER - The present invention relates to compositions, kits, and methods for providing a prognosis and/or determining a treatment course of action in a subject diagnosed with breast cancer. In particular, the present invention relates to gene expression signatures useful in the prognosis, diagnosis, and treatment of breast cancer. | 04-23-2015 |
20150159218 | METHOD FOR DETERMINING CLINICALLY RELEVANT HYPOXIA IN CANCER - The present invention provides a method for determining the oxygen status of a cancer of an individual. The method comprise determining the transcriptional expression level of ADM (SEQ ID No:1), and/or at least one gene selected from ANKRD37 (SEQ ID NO.: 3), P4HA2 (SEQ ID NO.: 12), NDRG1 (SEQ ID NO: 10), SLC2A1 (SEQ ID NO:15), P4HA1 (SEQ ID NO.: 11), LOX (SEQ ID NO.: 9), C3orf28 (SEQ ID NO.: 6), BNIP3L (SEQ ID NO.: 5), BNIP3 (SEQ ID NO.:4), EGLN3 (SEQ ID NO.: 7), PDK1 (SEQ ID NO.: 13), PFKFB3 (SEQ ID NO.: 14), KCTD11 (SEQ ID NO.: 8), and/or ALDOA (SEQ ID NO.: 2), in a cancer sample. The transcriptional level is then correlated to the transcriptional level to at least one reference gene, and oxygen status 10 is then evaluated by comparing the correlated transcription level with a predetermined reference sample comprising cancer cells characterized by a high oxygen level. | 06-11-2015 |
Jens Overgaard, Arhus C DK
Patent application number | Description | Published |
---|---|---|
20120040004 | TREATMENT OF RADIATION-INDUCED FIBROSIS - The present invention relates to treatment or prevention of radiation induced fibrosis using TNF-alpha antagonism. Preferably, TNF-alpha is antagonized by direct binding or by inhibition of synthesis. In a preferred embodiment, the invention comprises intraperitoneal administration of a chitosan-siRNA nanoparticle, wherein the siRNA is targeted to the mRNA encoding TNF-alpha. | 02-16-2012 |
Kenneth Overgaard, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110030173 | Attachment for clutchingly covering a major portion of a handle of a plunger, enhancing grip of the handle of the plunger, and absorbing shock from repeated thrusts of the plunger - An attachment for clutchingly covering a major portion of a handle of a plunger, enhancing grip of the handle of the plunger, and absorbing shock from repeated thrusts of the plunger. The attachment includes an end cap and a sleeve. The end cap covers the free end of the handle of the plunger and absorbs the shock from the repeated thrusts of the plunger. The sleeve depends from the end cap, clutchingly covers the major portion of the handle of the plunger, and enhances the grip of the handle of the plunger. | 02-10-2011 |
Michael Overgaard, Odense Nv DK
Patent application number | Description | Published |
---|---|---|
20110023758 | TELESCOPIC LIFTING COLUMN FOR HEIGHT ADJUSTMENT OF ELEVATABLE TABLES - A telescopic lifting column for height adjustment of elevatable tables ( | 02-03-2011 |
Michael Toft Overgaard, Gistrup DK
Patent application number | Description | Published |
---|---|---|
20150218636 | Mutations In Calmodulin Genes - The present invention relates to an isolated polynucleotide encoding at least a part of calmodulin and an isolated polypeptide comprising at least a part of a calmodulin protein, wherein the polynucleotide and the polypeptide comprise at least one mutation associated with a cardiac disorder. The present invention also relates to a method for determining whether an individual has an increased risk of contracting a cardiac disorder, a method for diagnosing a cardiac disorder, method for treatment of an individual having a cardiac disorder, method for identifying a compound, capable of enhancing the binding of calmodulin to ryanodine receptor 2 and use of such compound in a treatment of an individual having a cardiac disorder. The invention further provides a kit that can be used to detect specific mutations in calmodulin encoding genes. | 08-06-2015 |
Michael Toft Overgaard, Artus C DK
Patent application number | Description | Published |
---|---|---|
20130095482 | METHODS OF DETECTING PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) - The present invention provides pregnancy associated plasma protein A2 (PAPP-A2), its nucleotide and amino acid sequences, antisense molecules to the nucleotide sequences which encode PAPP-A2, expression vectors for the production of purified PAPP-A2, antibodies capable of binding specifically to PAPP-A2, hybridization probes or oligonucleotides for the detection of PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for the expression of PAPP-A2, and methods for screening for pathologies in pregnant and non-pregnant patients. Methods for screening for altered focal proliferation states in pregnant and/or non-pregnant patients, which include detecting levels of PAPP-A2, are also described. | 04-18-2013 |
20130095569 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) POLYNUCLEOTIDES - The present invention provides pregnancy associated plasma protein A2 (PAPP-A2), its nucleotide and amino acid sequences antisense molecules to the nucleotide sequences which encode PAPP-A2, expression vectors for the production of purified PAPP-A2, antibodies capable of binding specifically to PAPP-A2, hybridization probes or oligonucleotides for the detection of PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for the expression of PAPP-A2, and methods for screening for pathologies in pregnant and non-pregnant patients. Methods for screening for altered focal proliferation states in pregnant and/or non-pregnant patients, which include detecting levels of PAPP-A2, are also described. | 04-18-2013 |
Michael Toft Overgaard, Aarhus C DK
Patent application number | Description | Published |
---|---|---|
20150132770 | PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2) POLYNUCLEOTIDES - The present invention provides pregnancy associated plasma protein A2 (PAPP-A2), its nucleotide and amino acid sequences, antisense molecules to the nucleotide sequences which encode PAPP-A2, expression vectors for the production of purified PAPP-A2, antibodies capable of binding specifically to PAPP-A2, hybridization probes or oligonucleotides for the detection of PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for the expression of PAPP-A2, and methods for screening for pathologies in pregnant and non-pregnant patients. Methods for screening for altered focal proliferation states in pregnant and/or non-pregnant patients, which include detecting levels of PAPP-A2, are also described. | 05-14-2015 |
Michael Toft Overgaard, Arhus C. DK
Patent application number | Description | Published |
---|---|---|
20110091920 | METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX - The present invention provides a method of diagnosing Down's syndrome, acute coronary syndrome or pre-eclampsia, or a predisposition to any of them, by a method comprising measuring the level of the human PAPP-A/proMBP complex in a body fluid sample. | 04-21-2011 |
Peter Rosendal Overgaard, Ronde DK
Patent application number | Description | Published |
---|---|---|
20130058507 | METHOD FOR TRANSFERRING DATA TO A MUSICAL SIGNAL PROCESSOR - Transferring digital data to a musical signal processor by a method comprising establishing a connection from a musical transducer to the musical signal processor, the musical transducer being of a type that converts a wireless type of signal into an electrical signal; exposing the musical transducer to a wireless data signal comprising the digital data, whereby the wireless data signal is converted into an electrical data signal by the musical transducer; and receiving and decoding the electrical data signal at the musical signal input of the musical signal processor. According to a preferred embodiment of the invention the musical transducer is a guitar pickup, the musical signal processor is a guitar pedal or other guitar signal processor, and the wireless data signal is a magnetic signal established by an electro-dynamic speaker of a smartphone or the like. | 03-07-2013 |
Rune Viig Overgaard, Copenhagen DE
Patent application number | Description | Published |
---|---|---|
20150197569 | ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF - A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer. | 07-16-2015 |
Rune Viig Overgaard, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20100189723 | ANTI-KIR ANTIBODIES, FORMULATIONS, AND USES THEREOF - A novel IgG4 isotype anti-KIR antibody, novel formulations of this and other IgG4 anti-KIR antibodies, and methods of using such formulations are provided. Also described are compositions, formulations, dosages, and administration regimens suitable for NK cell activation and therapeutic applications of anti-KIR antibodies, as well as kits comprising one or more anti-KIR antibodies with instructions for use in treating cancer. | 07-29-2010 |
Torben Overgaard, Northampton GB
Patent application number | Description | Published |
---|---|---|
20100263309 | FACADE PANEL AND BUILDING FACADE - Building façade attachable to a building. The building façade includes at least two horizontally adjacent façade panels. Each respective façade panel including horizontal top and bottom edges and two vertical side edges. At least one recess is arranged on a surface of each respective façade panel directed towards the building. The at least one recess is arranged parallel to the two vertical side edges. At least one groove is arranged on the horizontal bottom edge of each respective façade panel. A mounting construction has at least one attachment element extending into the at least one groove of each respective façade panel and at least one guiding projection extending into the at least one vertical recess of each respective façade panel. The at least two horizontally adjacent façade panels are aligned approximately parallel to one another. | 10-21-2010 |